Home / Ranibizumab / Canada
CA ATC S01LA04 · updated 2 Nov 2026
Ranibizumab shortage in Canada
Is there a Ranibizumab shortage in Canada?
Yes. As of 2 Nov 2026, 2 Ranibizumab products are reported short in Canada, the first since 1 Jan 2026. The company estimate for the return is 30 Jun 2027. Main reason: other.
Also short in Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | BYOOVIZ (Vial + filter needle + injection needle pack & Vial only pack) | SAMSUNG BIOEPIS CO., LTD | 1 Jan 2026 | 30 Jun 2027 | Other Other (Please describe in comments) |
| CA | LUCENTIS (1) discontinuation | NOVARTIS PHARMACEUTICALS CANADA INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.